Results 181 to 190 of about 90,058 (326)
SELECTIVE INHIBITION OF PSEUDO‐CHOLINESTERASE BY DIISOPROPYL FLUOROPHOSPHONATE [PDF]
Richard Hawkins, B Mendel
openalex +1 more source
Role of 18F‐florzolotau PET in diagnostic and therapeutic decision‐making for cognitive impairment
Abstract INTRODUCTION The novel positron emission tomography (PET) tracer, 18F‐florzolotau, enables in vivo visualization of tau pathology. METHODS We evaluated the diagnostic performance of disease‐specific spatial patterns of 18F‐florzolotau PET imaging by visual read for tauopathies and its added value in diagnostic and therapeutic decision‐making ...
Jun Wang+17 more
wiley +1 more source
Case report: Treatment of severe phorate poisoning. [PDF]
Kunlun W+6 more
europepmc +1 more source
Cholinergic Degeneration and Cognitive Function in Early GBA1‐Related Parkinson's Disease
Objective The phenotype of patients with Parkinson's disease carrying GBA1 variants (GBA‐PD) suggest similarities to symptomatology associated with early cholinergic system degeneration. Therefore, this study aims to investigate the clinical features and the cholinergic innervation pattern in patients with early GBA‐PD versus those without the GBA1 ...
Sofie Slingerland+6 more
wiley +1 more source
Fluorometric and Colorimetric Biosensors for the Assay of Cholinesterase Inhibitors. [PDF]
Pohanka M.
europepmc +1 more source
Experiments with Methyl-fluoro-phosphorylcholine-inhibited Cholinesterase. [PDF]
Inger Enander+5 more
openalex +1 more source
ABSTRACT This study explores the potential of Thymus ciliatus as a natural source of bioactive compounds by investigating its chemical composition and in vitro biological activities, including antioxidant, antimicrobial, antidiabetic, and anti‐Alzheimer properties.
Nadia Djermane+8 more
wiley +1 more source
THE PRODUCTION OF BLOCK AND AURICULAR FIBRILLATION IN THE HEART-LUNG PREPARATION BY INHIBITORS OF CHOLINESTERASE [PDF]
J. H. Burn+2 more
openalex +1 more source
The METAB‐HTX trial is a prospective cohort study, evaluating cardiac and systemic metabolism among heart transplant recipients. Myocardial function, energetic and metabolism, allograft vasculopathy, allograft rejection, glucometabolism, lipometabolism, liver‐ and kidney function, leucocyte signatures and thromboinflammation will be evaluated ...
Amin Polzin+21 more
wiley +1 more source